- Login
- Register & Subscribe
- Langue: EN FR DE
Research & University News
TB alliance tests novel tuberculosis regime
Monday 8 November 2010
The Global Alliance for TB Drug Development has launched a clinical trial to test a novel three-drug regime for tuberculosis which, it says, shows promise for treating both drug-sensitive and multidrug-resistant forms of the disease.
Location
Germany
Antibodies said to attack viruses within cells
Wednesday 3 November 2010
Researchers funded by the UK Medical Research Council have reported that the human body has a system of intracellular immunity by which antibodies can fight viruses from within infected cells.
Location
United Kingdom
UK launches a new type of life-science cluster
Monday 25 October 2010
The UK government has launched two new life science clusters that will bring experts from industry, the academic community and the National Health Service together to do early-stage drug development.
Location
United Kingdom
German cancer centre and Roche in diagnostics deal
Monday 11 October 2010
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and Roche Molecular Systems Inc have entered into a three-year collaboration to find out if they can predict a woman’s risk for developing cervical cancer.
Location
Germany
FDA awards $2.9 million for TB research
Wednesday 6 October 2010
The US Food and Drug Administration has awarded $2.9 million to support six research projects aimed at helping with the diagnosis, treatment and prevention of tuberculosis. The awards were issued under the agency’s Critical Path Initiative.
Location
United States
Novartis drops two drug programmes
Tuesday 5 October 2010
Novartis International AG said it is stopping work on albinterferon alfa-2b for hepatitis C and Mycograb (efungumab) for fungal infections in order to focus on more promising products. It will take a charge of $590 million in the third quarter.
Location
Switzerland
UK early-stage, life-science funding spread too thin, study shows
Friday 24 September 2010
A study of life-science start-ups in Britain over the five years to 2009 shows that investment per start-up in some regions is too small to ensure that the companies can be sustainable.
Location
United Kingdom
Genome of the Tasmanian devil sequenced
Wednesday 22 September 2010
Researchers from the Wellcome Trust Sanger Institute in the UK and Illumina Inc of the US have mapped the genome of the Tasmanian devil, a mammal that is confronted with extinction because of infection with a transmissible facial cancer.
Location
United Kingdom
Oxford Nanopore extends collaboration with Oxford University
Wednesday 15 September 2010
Oxford Nanopore Technologies Ltd has strengthened its ties with Oxford University in the UK in order to explore new applications for its sequencing technology to the field of protein sensing.
Location
United Kingdom
Researchers identify genetic link to migraine
Monday 30 August 2010
Investigators working for a Wellcome Trust Sanger Institute-funded study have found that patients with a particular DNA variant may experience a build-up of glutamate in nerve cell junctions of the brain, a process that is thought to lead to migraine attacks.
Location
United Kingdom
Select a News Category
Recent Appointments
Steffen Thirstrup joins NDA Group
Monday June 10 2013
Tarquin Bennett-Coles joins Odgers Berndtson
Monday June 10 2013
Sandy Eisen becomes non-executive director at Phosphate Therapeutics
Thursday June 6 2013
Eric-Paul Paques to chair Grünenthal
Thursday June 6 2013
Charles DeCarli joins advisory board at DiaGenic
Thursday June 6 2013